Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure

Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement... Key PointsQuestionWhat are the utilization rates, patient characteristics, and outcomes of implantable cardioverter-defibrillator or cardiac resynchronization therapy-defibrillator placement among patients with advanced heart failure? FindingsAmong 81 492 Medicare patients in this cohort study, a small proportion of initial implantable cardioverter-defibrillator or cardiac resynchronization therapy-defibrillator placements for primary prevention of sudden cardiac death occurred in older patients with advanced heart failure. One-year all-cause mortality was 22%, more than 3-fold higher than that in patients without advanced heart failure, and patients with advanced heart failure had a periprocedural complication rate of 3.7%, primarily driven by in-hospital fatality or cardiac arrest. MeaningAmong patients undergoing these procedures, only a small proportion had advanced heart failure, and these patients experienced clinically important periprocedural complication rates. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure

Loading next page...
 
/lp/american-medical-association/periprocedural-risk-and-survival-associated-with-implantable-lr3SQhayCe

References (17)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2020.0391
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionWhat are the utilization rates, patient characteristics, and outcomes of implantable cardioverter-defibrillator or cardiac resynchronization therapy-defibrillator placement among patients with advanced heart failure? FindingsAmong 81 492 Medicare patients in this cohort study, a small proportion of initial implantable cardioverter-defibrillator or cardiac resynchronization therapy-defibrillator placements for primary prevention of sudden cardiac death occurred in older patients with advanced heart failure. One-year all-cause mortality was 22%, more than 3-fold higher than that in patients without advanced heart failure, and patients with advanced heart failure had a periprocedural complication rate of 3.7%, primarily driven by in-hospital fatality or cardiac arrest. MeaningAmong patients undergoing these procedures, only a small proportion had advanced heart failure, and these patients experienced clinically important periprocedural complication rates.

Journal

JAMA CardiologyAmerican Medical Association

Published: Jun 25, 2020

There are no references for this article.